De-escalation of radiation therapy in patients with stage I, node-negative, HER2-positive breast cancer
Abstract In the modern era, highly effective anti-HER2 therapy is associated with low local-regional recurrence (LRR) rates for early-stage HER2+ breast cancer raising the question of whether local therapy de-escalation by radiation omission is possible in patients with small-node negative tumors tr...
Guardado en:
Autores principales: | Jose G. Bazan, Sachin R. Jhawar, Daniel Stover, Ko Un Park, Sasha Beyer, Erin Healy, Julia R. White |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9924a15756c443988ef0afef40bd20e6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ESCALATING APPLICATIONS OF HALLOYSITE NANOTUBES
por: SAIF,MUHAMMAD JAWWAD, et al.
Publicado: (2015) -
Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer
por: Hanne Vos, et al.
Publicado: (2021) -
Glycogen–gold nanohybrid escalates the potency of silymarin
por: Kandimalla R, et al.
Publicado: (2017) -
Five-year follow-up of treatment outcomes in patients with early-stage breast cancer and clinically negative axillary nodes treated with no lymph node dissection or axillary clearance
por: Yamamoto D, et al.
Publicado: (2012) -
Bevacizumab in the treatment of HER2-negative breast cancer
por: Vito Lorusso
Publicado: (2008)